<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03947697</url>
  </required_header>
  <id_info>
    <org_study_id>1233722</org_study_id>
    <nct_id>NCT03947697</nct_id>
  </id_info>
  <brief_title>A Novel Treatment Intervention for Improving Metabolism</brief_title>
  <official_title>Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas, El Paso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas, El Paso</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Once written consent is obtained, the participant will be provided with an accelerometer to
      be worn for 7 days to assess current physical activity levels. Subjects will be provided with
      a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of
      insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation
      intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance
      training combined with NMES (RT +NMES), or resistance training (RT) group (n=15 per group),
      followed by collection of post-intervention data. The control group will receive electrical
      stimulation up to sensory level, the NMES group will receive stimulation up to tolerable
      intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to
      tolerable intensity during resistance training, and the RT group will only receive exercise
      training. Pre-and post-intervention data includes measurements for body composition, resting
      metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 12, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oral Glucose Tolerance Test</measure>
    <time_frame>8 weeks</time_frame>
    <description>Insulin Sensitivity will be measured through repeated blood sampling during an Oral Glucose Tolerance Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory Exchange Ratio</measure>
    <time_frame>8 Weeks</time_frame>
    <description>Respiratory Exchange Ratio will be used to quantify substrate utilization (fats vs carbohydrates) through the use of indirect calorimetry of in vivo gas exchange</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of lean mass</measure>
    <time_frame>8 Weeks</time_frame>
    <description>Amount of lean mass will be measured by dual energy x-ray absortiometry</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Obesity</condition>
  <condition>Overweight</condition>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive stimulation only up to sensory level.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NMES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive stimulation up to maximum tolerable level.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistance Training</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive exercise training with stimulation up to sensory level.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistance Training + NMES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive exercise training with stimulation up to maximum tolerable intensity.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuromuscular Electrical Stimulation (Sensory)</intervention_name>
    <description>Group will receive Electrical Stimulation up to sensory level</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Resistance Training</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuromuscular Electrical Stimulation</intervention_name>
    <description>Group will receive Electrical Stimulation up to maximum tolerable level</description>
    <arm_group_label>NMES</arm_group_label>
    <arm_group_label>Resistance Training + NMES</arm_group_label>
    <other_name>NMES Group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance Training</intervention_name>
    <description>Group will receive exercise training.</description>
    <arm_group_label>Resistance Training</arm_group_label>
    <arm_group_label>Resistance Training + NMES</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight/Obese (BMI â‰¤25)

          -  Sedentary Lifestyle: Physical Activity Level&lt;1.4

          -  Less than 150min/week of structured Exercise

        Exclusion Criteria:

          -  Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications

          -  Excessive alcohol, drug abuse, smoking

          -  Pregnant Women

          -  Unwilling to adhere to the study Intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sudip Bajpeyi, PhD</last_name>
    <phone>9157475461</phone>
    <email>sbajpeyi@utep.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Texas at El Paso</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79968</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sudip R Bajpeyi, PhD</last_name>
      <phone>915-747-5461</phone>
      <email>sbajpeyi@utep.edu</email>
    </contact>
    <investigator>
      <last_name>Jasmin Jenkins, B.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michelle Galvan, B.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>December 7, 2018</study_first_submitted>
  <study_first_submitted_qc>May 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2019</study_first_posted>
  <last_update_submitted>August 18, 2019</last_update_submitted>
  <last_update_submitted_qc>August 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas, El Paso</investigator_affiliation>
    <investigator_full_name>Sudip Bajpeyi</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

